Detalhe da pesquisa
1.
GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.
J Pathol
; 257(2): 158-171, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35072947
2.
Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.
J Pathol
; 255(4): 425-437, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431104
3.
MicroRNA-141-3p regulates cellular proliferation, migration, and invasion in esophageal cancer by targeting tuberous sclerosis complex 1.
Mol Carcinog
; 60(2): 125-137, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382472
4.
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
Prostate
; 80(12): 1012-1023, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649013
5.
Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology.
Am J Pathol
; 188(7): 1530-1535, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684363
6.
Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.
Am J Pathol
; 181(1): 111-20, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22634180
7.
An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss.
Nat Commun
; 13(1): 6808, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357396
8.
Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway.
J Biol Chem
; 284(27): 17947-55, 2009 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19383984
9.
mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation.
J Clin Invest
; 129(12): 5584-5599, 2019 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527310
10.
mTORC1 loss impairs epidermal adhesion via TGF-ß/Rho kinase activation.
J Clin Invest
; 127(11): 4001-4017, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945203
11.
The HER2- and heregulin ß1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.
Mol Cancer Res
; 11(4): 393-404, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23378579
12.
The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment.
J Invest Dermatol
; 133(4): 1052-62, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23190886